ProKidney Corp.
PROK | NASDAQ
$1.77
-$0.14 (-7.33%)
At close: Sep 21, 2026, 4:00 PM ET
$1.77
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Market Data
Market Cap $642.24M
Enterprise Value $417.68M
Beta 1.75
Average Volume 1.13M
Shares Outstanding (Diluted) 186.56M
Shares Change YoY 42.71%
Institutional Ownership 30.05%
Exchange NASDAQ
ISIN US74291D1046
Price Performance
Price Change 1M 11.3%
Price Change 3M -1.7%
Price Change 6M -3.3%
Price Change YTD -20.6%
Price Change 1Y -37.0%
Price Change 3Y -63.4%
Price Change 5Y -81.9%
1M CAGR (ann.) 16.5%
1Y CAGR (ann.) -24.5%
5Y CAGR (ann.) -27.9%
All-Time CAGR -27.3%
Valuation
PE Ratio -3.11
Forward PE N/A
PEG Ratio 3.80
Forward PEG -3.73
PS Ratio 729.65
Forward PS 1,449.30
PB Ratio 2.68
P/FCF Ratio -3.74
P/Adj. FCF Ratio -3.39
P/OCF Ratio -2.33
EV/Sales 510.61
EV/EBIT -2.50
EV/EBITDA -2.60
EV/FCF -2.61
Earnings Yield -32.2%
FCF Yield -26.8%
Adj. FCF Yield -29.5%
Financial Health
Net Cash $179.17M
Total Debt $2.39M
Cash & Short-Term Investments $181.56M
Total Assets $249.02M
Current Ratio 8.36
Quick Ratio 8.36
Debt / Equity Ratio -0.00
Debt / EBITDA -0.01
Debt / FCF -0.02
OCF / Debt -58.97
Interest Coverage -9,327.16
Altman Z-Score 5.91
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -252.6%
Operating Profit Margin -21664.5%
EBITDA Margin -19651.8%
Net Profit Margin -10599.8%
FCF Margin -19527.4%
Adj. FCF Margin -21513.0%
SBC / Revenue 1985.6%
SBC Impact (per share) -10.2%
Returns
Return on Assets -34.8%
Return on Equity 8.8%
Return on Invested Capital -68.1%
Return on Capital Employed -78.3%
Return on Tangible Assets -34.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 91.2%
Revenue CAGR 5Y 80.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 2.6%
EPS CAGR 5Y 9.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -2.1%
FCF CAGR 5Y -11.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 17.0%
Revenue Growth Next 3Y 439.7%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.12
EPS Growth Est (next Q) 0.0%
Revenue Est (next Q) $124.6K
Revenue Growth Est (next Q) -42.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.67
Price Target Upside 163.8%
Cash Flow
Operating Cash Flow $-141.17M
Free Cash Flow $-159.73M
Adj. Free Cash Flow $-175.98M
FCF Per Share -$0.86
OCF Per Share -$0.76
OCF/S Ratio -17257.6%
Income Statement
Revenue $818K
Gross Profit $-2.07M
Operating Income $-177.22M
EBITDA $-160.75M
Net Income $-86.71M
EPS (Diluted) -$0.57
Revenue / Employee $3.54K
Profit / Employee $-375.35K
Employees 231
Add to Watchlist
Select watchlists to add or remove PROK